Molecular basis for hypertension in the "type II variant" of apparent mineralocorticoid excess (Q24539134)

6 July 2017

title

Molecular basis for hypertension in the "type II variant" of apparent mineralocorticoid excess (English)

1 reference

6 July 2017

0 references

arterial hypertension

1 reference

Li A

1

1 reference

6 July 2017

Tedde R

2

1 reference

6 July 2017

Krozowski ZS

3

1 reference

6 July 2017

Pala A

4

1 reference

6 July 2017

Li KX

5

1 reference

6 July 2017

Shackleton CH

6

1 reference

6 July 2017

Mantero F

7

1 reference

6 July 2017

Palermo M

8

1 reference

6 July 2017

Stewart PM

9

1 reference

6 July 2017

language of work or name

English

0 references

publication date

1 August 1998

1 reference

American Journal of Human Genetics

6 July 2017

published in

1 reference

6 July 2017

volume

63

1 reference

6 July 2017

issue

2

1 reference

6 July 2017

page(s)

370-379

1 reference

Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor

6 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1377297

Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1377297

Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1377297

11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1377297

Human hypertension caused by mutations in the kidney isozyme of 11β–hydroxysteroid dehydrogenase

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1377297

A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1377297

Several homozygous mutations in the gene for 11 beta-hydroxysteroid dehydrogenase type 2 in patients with apparent mineralocorticoid excess

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1377297

Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1377297

Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1377297

The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1377297

Immunodetection of 11 beta-hydroxysteroid dehydrogenase type 2 in human mineralocorticoid target tissues: evidence for nuclear localization

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1377297

Apparent mineralocorticoid excess: type I and type II.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1377297

Molecular basis of human 3 beta-hydroxysteroid dehydrogenase deficiency.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1377297

Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1377297

Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1377297

Evidence for cortisol as the mineralocorticoid in the syndrome of apparent mineralocorticoid excess

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1377297

A Syndrome of Apparent Mineralocorticoid Excess Associated with Defects in the Peripheral Metabolism of Cortisol*

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1377297

Point mutations abolish 11 beta-hydroxysteroid dehydrogenase type II activity in three families with the congenital syndrome of apparent mineralocorticoid excess.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1377297

Apparent mineralocorticoid excess: genotype is correlated with biochemical phenotype

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1377297

Pathogenesis of the type 2 variant of the syndrome of apparent mineralocorticoid excess

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1377297

Human kidney 11 beta-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type I isoform

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1377297

Apparent mineralocorticoid excess syndromes

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1377297

Heterogeneous hypertension

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1377297

New findings in apparent mineralocorticoid excess

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1377297

Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excess

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1377297

Defects in the HSD11 gene encoding 11 beta-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1377297

The Syndrome of Apparent Mineralocorticoid Excess: Its Association with 1 lβ –Dehydrogenase and 5β –Reductase Deficiency and Some Consequences for Corticosteroid Metabolism*

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1377297

The R337C mutation generates a high Km 11 beta-hydroxysteroid dehydrogenase type II enzyme in a family with apparent mineralocorticoid excess

29 November 2018

1 reference

12 December 2020

Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man

1 reference

12 December 2020

Investigation of urinary steroid profiles as a diagnostic method in Cushing's syndrome

1 reference

12 December 2020

Metabolic and Blood Pressure Responses to Hydrocortisone in the Syndrome of Apparent Mineralocorticoid Excess*

1 reference

12 December 2020

Congenital 11 beta-hydroxysteroid dehydrogenase deficiency associated with juvenile hypertension: corticosteroid metabolite profiles of four patients and their families

1 reference

12 December 2020

LOCALISATION OF 11β-HYDROXYSTEROID DEHYDROGENASE—TISSUE SPECIFIC PROTECTOR OF THE MINERALOCORTICOID RECEPTOR

1 reference

12 December 2020

Apparent mineralocorticoid excess in a Brazilian kindred

1 reference

12 December 2020

Licorice-induced hypermineralocorticoidism

1 reference

12 December 2020

Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research

1 reference

12 December 2020

Apparent mineralocorticoid excess type II

1 reference

12 December 2020

Type 2 11 beta-hydroxysteroid dehydrogenase in human fetal tissues

1 reference

12 December 2020

Evidence of coexisting changes in 11 beta-hydroxysteroid dehydrogenase and 5 beta-reductase activity in subjects with untreated essential hypertension

1 reference

12 December 2020

Detection of human 11 beta-hydroxysteroid dehydrogenase isoforms using reverse-transcriptase-polymerase chain reaction and localization of the type 2 isoform to renal collecting ducts

1 reference

Crossref

https://api.crossref.org/works/10.1086/301955

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1086/301955

1 reference

6 July 2017

1 reference

6 July 2017

1 reference